<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

qz
Moderna beat earnings expectations but its norovirus vaccine trial hit a wall

The company topped Wall Street loss estimates, but its norovirus vaccine missed a key trial goal, sending shares lower [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
Beat Saber support is ending on PS VR and PS VR2

It's the end of the line for Beat Saber on PS VR and PS VR2. While you'll still be able to buy and play the base game on both platforms, as well as any songs and music packs that were releas [...]

Match Score: 59.48

Destination
Moderna and other vaccines stocks are down after the FDA's top vaccine official resigns

Moderna (MRNA) and other vaccine maker stocks plummeted during pre-market trading on Monday amid news from this weekend that the Food and Drug Administration’s (FDA) top vaccine regulator was forced [...]

Match Score: 52.22

Destination
Saliva that fights norovirus? Experimental oral vaccine is nothing to spit at.

Phase I study showed vaccine was safe and spurred immune responses in older people. [...]

Match Score: 49.02

qz
Moderna is developing an mRNA Ebola vaccine as a deadly outbreak spreads through Congo

CEPI is committing up to $50 million to support Moderna's vaccine candidate for the strain with no approved shot [...]

Match Score: 43.16

Destination
Moderna says mRNA flu vaccine sailed through trial, beating standard shot

Moderna hailed the results, but the shot's future under RFK Jr. is murky. [...]

Match Score: 40.56

qz
Moderna stock sags with the market even after beating Wall Street earnings bets and job cuts

Moderna second-quarter earnings surpassed Wall Street's expectations amid a reduction to its global workforce and dropping Covid-19 sales [...]

Match Score: 40.39

qz
Moderna and Merck's personalized skin cancer vaccine cleared its first large-scale trial

The mRNA-based vaccine combined with Keytruda reduced melanoma recurrence in more than 1,100 patients whose cancer had been surgically removed [...]

Match Score: 39.49

qz
Moderna mRNA flu vaccine bests standard shot in peer-reviewed trial, FDA decision due in August

Results published in the New England Journal of Medicine show the mRNA shot reduced flu illness by about 27% more than a standard-dose vaccine [...]

Match Score: 39.48

Destination
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

The vaccine reportedly thwarted the cancer's return and spread. [...]

Match Score: 39.48